Oncogenic NOVA1 expression dysregulates alternative splicing in breast cancer
Daniel F. Moakley, Ye Wang, Chaolin Zhang
This study shows that NOVA1 overexpression in breast cancer disrupts alternative splicing, particularly in genes related to cell communication and cytoskeleton, and is linked to worse outcomes in Luminal A tumors.
RNA · Jun 3, 2026Peer-reviewedCancer Biology